(VRNA) Verona Pharma - Performance 366.5% in 12m
Compare VRNA with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
93.57%
#1 in Group
Rel. Strength
99.55%
#37 in Universe
Total Return 12m
366.47%
#3 in Group
Total Return 5y
1697.26%
#1 in Group
P/E -
(?) Percentile in Group
P/E Forward 435
94th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -1.46%
(?) Percentile in Group
12m Total Return: VRNA (366.5%) vs XLV (1.7%)
5y Drawdown (Underwater) Chart
Top Performers in Pharmaceuticals
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| CORT NASDAQ Corcept Therapeutics |
-37.1% | 208% | 466% | 57.7 | 43.5 | 0.61 | 55.9% | 3.42% |
| LLY NYSE Eli Lilly |
8.84% | 15.8% | 523% | 75.7 | 38.9 | 1.41 | 41.1% | 48.6% |
| NVS NYSE Novartis |
1.8% | 21.1% | 74.9% | 19.2 | 13.7 | 1.3 | 35.8% | 4.22% |
| SFZN SW Siegfried Holding |
8.63% | 12.1% | 131% | 24.1 | 22.1 | 1.41 | 66.7% | 72.5% |
| NOVN SW Novartis |
-4.14% | 9.09% | 50% | 19.2 | 13.5 | 1.29 | 35.8% | 3.8% |
| SOBI ST Swedish Orphan Biovitrum |
1.95% | 2.66% | 56.9% | 24.7 | 20.6 | 1.59 | 7.30% | 30.4% |
| SAN PA Sanofi |
-5.91% | 7.31% | 26.6% | 18.5 | 11.2 | 0.9 | -20.4% | 16.2% |
| SUPN NASDAQ Supernus Pharmaceuticals |
-0.82% | 7.91% | 46.7% | 24.4 | 20.2 | 1.47 | -13.6% | -12.5% |
Performance Comparison: VRNA vs XLV vs S&P 500
XLV (Health Care Sector SPDR ETF) is the Sector Benchmark for VRNA
| Total Return (including Dividends) | VRNA | XLV | S&P 500 |
|---|---|---|---|
| 1 Month | 13.51% | -3.79% | -0.87% |
| 3 Months | 25.78% | -3.99% | -7.58% |
| 12 Months | 366.47% | 1.72% | 11.88% |
| 5 Years | 1697.26% | 55.40% | 110.33% |
| Trend Score (consistency of price movement) | VRNA | XLV | S&P 500 |
| 1 Month | 76.0% | -3.2% | 23% |
| 3 Months | 0.10% | -71.4% | -88.5% |
| 12 Months | 97.6% | -17.5% | 55.1% |
| 5 Years | 80.7% | 89.8% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLV | vs. S&P 500 |
| 1 Month | #35 | 18.0% | 14.5% |
| 3 Month | #15 | 31.0% | 36.1% |
| 12 Month | #3 | 359% | 317% |
| 5 Years | #1 | 1,057% | 755% |
FAQs
Does VRNA Verona Pharma outperforms the market?
Yes,
over the last 12 months VRNA made 366.47%, while its related Sector, the Health Care Sector SPDR (XLV) made 1.72%.
Over the last 3 months VRNA made 25.78%, while XLV made -3.99%.
Over the last 3 months VRNA made 25.78%, while XLV made -3.99%.
Performance Comparison VRNA vs Indeces and Sectors
VRNA vs. Indices VRNA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 10.3% | 14.4% | 114% | 355% |
| US NASDAQ 100 | QQQ | 9.24% | 12.1% | 114% | 354% |
| US Dow Jones Industrial 30 | DIA | 11.2% | 16.7% | 114% | 357% |
| German DAX 40 | DAX | 11.5% | 12.2% | 94.8% | 342% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 14.2% | 16.3% | 117% | 361% |
| Hongkong Hang Seng | HSI | 11.3% | 13.5% | 112% | 353% |
| India NIFTY 50 | INDA | 13.1% | 9.45% | 114% | 363% |
| Brasil Bovespa | EWZ | 11.1% | 8.91% | 111% | 372% |
VRNA vs. Sectors VRNA is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 10.0% | 14.6% | 108% | 343% |
| Consumer Discretionary | XLY | 10.2% | 13.6% | 112% | 353% |
| Consumer Staples | XLP | 13.8% | 13.3% | 109% | 355% |
| Energy | XLE | 14.8% | 27.4% | 120% | 378% |
| Financial | XLF | 11.7% | 15.6% | 107% | 344% |
| Health Care | XLV | 10.4% | 17.3% | 116% | 365% |
| Industrial | XLI | 9.85% | 13.4% | 114% | 357% |
| Materials | XLB | 10.9% | 15.9% | 122% | 370% |
| Real Estate | XLRE | 11.8% | 14.8% | 115% | 348% |
| Technology | XLK | 7.82% | 11.8% | 118% | 359% |
| Utilities | XLU | 13.1% | 13.5% | 112% | 345% |
| Aerospace & Defense | XAR | 9.32% | 7.12% | 101% | 340% |
| Biotech | XBI | 8.97% | 11.2% | 127% | 368% |
| Homebuilder | XHB | 11.0% | 15.8% | 129% | 374% |
| Retail | XRT | 11.8% | 14.1% | 120% | 369% |